NEW YORK (GenomeWeb) – Shanghai-based biotechnology company Realbio Technology announced that it has raised RMB 40 million ($5.9 million) in a pre-A Series financing round.

Realbio, which was founded in 2014, uses high-throughput DNA sequencing technology to conduct microbiome studies and test clinical samples. It specializes in the enrichment and analysis of genes and microbiomes in fecal specimens. In an email to GenomeWeb, a company spokesman said Realbio uses Illumina platforms, mainly the HiSeq and MiSeq, to conduct its studies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.